Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Helderman

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Clinical Transplants|January 1, 1995
Update in transplantation 1995J H Helderman, S Goral
Diabetes|July 1, 1980
The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defectJ H Helderman, P Raskin
Seminars in Nephrology|January 29, 2000
Transplantation for the millennium: attaining tolerance in our time--the Holy GrailJ H Helderman, S Goral
The New England Journal of Medicine|January 27, 1983
Dialysis and transplantation in end-stage lupus nephritisM Ziff, J H Helderman
Immunopharmacology and Immunotoxicology|January 1, 1992
The impact of acemannan on the generation and function of cytotoxic T-lymphocytesD Womble, J H Helderman
International Journal of Immunopharmacology|January 1, 1988
Enhancement of allo-responsiveness of human lymphocytes by acemannan (Carrisyn)D Womble, J H Helderman
Transplantation Proceedings|October 1, 1994
Cytomegalovirus and rejectionS Goral, J H Helderman
The New England Journal of Medicine|November 5, 1999
The allocation of cadaveric kidneysJ H Helderman, S Goral
Transplantation|June 27, 2000
Is there hope to improve chronic renal allograft outcome?S Goral, J H Helderman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1983
Transplantation 1983J H Helderman, P Gailiunas
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Clinical Transplants|January 1, 1995
Update in transplantation 1995J H Helderman, S Goral
Diabetes|July 1, 1980
The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defectJ H Helderman, P Raskin
Seminars in Nephrology|January 29, 2000
Transplantation for the millennium: attaining tolerance in our time--the Holy GrailJ H Helderman, S Goral
The New England Journal of Medicine|January 27, 1983
Dialysis and transplantation in end-stage lupus nephritisM Ziff, J H Helderman
Immunopharmacology and Immunotoxicology|January 1, 1992
The impact of acemannan on the generation and function of cytotoxic T-lymphocytesD Womble, J H Helderman
International Journal of Immunopharmacology|January 1, 1988
Enhancement of allo-responsiveness of human lymphocytes by acemannan (Carrisyn)D Womble, J H Helderman
Transplantation Proceedings|October 1, 1994
Cytomegalovirus and rejectionS Goral, J H Helderman
The New England Journal of Medicine|November 5, 1999
The allocation of cadaveric kidneysJ H Helderman, S Goral
Transplantation|June 27, 2000
Is there hope to improve chronic renal allograft outcome?S Goral, J H Helderman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1983
Transplantation 1983J H Helderman, P Gailiunas
Pageof 12